ZIPRASIDONE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C21H21ClN4OS
Molecular Weight	412.936
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of ZIPRASIDONE

Structure Search

SMILES

ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=C4C=CC=C5

InChI

InChIKey=MVWVFYHBGMAFLY-UHFFFAOYSA-N

InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)

HIDE SMILES / InChI

Molecular Formula	C21H21ClN4OS
Molecular Weight	412.936
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 17:53:51 UTC 2023` Edited by `admin` on `Sat Dec 16 17:53:51 UTC 2023`
Record UNII	6UKA5VEJ6X
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ZIPRASIDONE

Official Name

English

ZIPRASIDONE [HSDB]

Common Name

English

ziprasidone [INN]

Common Name

English

ZIPRASIDONE [MI]

Common Name

English

Ziprasidone [WHO-DD]

Common Name

English

ZIPRADON

Brand Name

English

ZIPRASIDONE [MART.]

Common Name

English

ZIPRASIDONE [VANDF]

Common Name

English

Classification Tree Code System Code

LIVERTOX

NBK548663

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

WHO-VATC

QN05AE04

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

NDF-RT

N0000175430

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

NCI_THESAURUS

C29710

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

WHO-ATC

N05AE04

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

Code System Code Type Description

CHEBI

10119

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

PUBCHEM

60854

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

IUPHAR

59

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

SMS_ID

100000078790

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

RXCUI

115698

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

RxNorm

DAILYMED

6UKA5VEJ6X

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

ChEMBL

CHEMBL708

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

DRUG BANK

DB00246

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

WIKIPEDIA

ZIPRASIDONE

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

MESH

C092292

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

EVMPD

SUB00168MIG

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

LACTMED

Ziprasidone

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

HSDB

7745

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

INN

7155

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

DRUG CENTRAL

2865

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

FDA UNII

6UKA5VEJ6X

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

EPA CompTox

DTXSID4023753

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

NCI_THESAURUS

C47788

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

MERCK INDEX

m11641

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

Merck Index

CAS

146939-27-7

Created by admin on Sat Dec 16 17:53:54 UTC 2023 , Edited by admin on Sat Dec 16 17:53:54 UTC 2023

PRIMARY

Related Record Type Details


					JAL53626GG

ZIPRASIDONE HYDROCHLORIDE ANHYDROUS

SALT/SOLVATE -> PARENT


					3X6SAX83JZ

ZIPRASIDONE MESYLATE

SALT/SOLVATE -> PARENT


					19GBD6T9L7

D(2) DOPAMINE RECEPTOR

TARGET -> INHIBITOR


					JAL53626GG

ZIPRASIDONE HYDROCHLORIDE ANHYDROUS

SALT/SOLVATE -> PARENT


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					D9KF7S3KAH

DIZIPRASIDONE DEGRADANT

DEGRADENT -> PARENT


					AO4E1LXT7Z

ZIPRASIDONE HYDROGEN SULFATE DIHYDRATE

SALT/SOLVATE -> PARENT


					216X081ORU

ZIPRASIDONE HYDROCHLORIDE

SALT/SOLVATE -> PARENT


					50U1BO5G5P

ALPHA-2A ADRENERGIC RECEPTOR

TARGET -> AGONIST

Interaction Type:

SHORT-ACTING


					NQI5D806LC

5-HYDROXYTRYPTAMINE RECEPTOR 2A

TARGET -> INHIBITOR


					216X081ORU

ZIPRASIDONE HYDROCHLORIDE

SALT/SOLVATE -> PARENT


					3X6SAX83JZ

ZIPRASIDONE MESYLATE

SALT/SOLVATE -> PARENT

Related Record Type Details


					6BZX6ST0LP

ZIPRASIDONE SULFONE

METABOLITE -> PARENT


					5VV7CA4473

ZIPRASIDONE SULFOXIDE

METABOLITE -> PARENT

Interaction Type:

MAJOR


					59D8RAT1F9

3-(1-PIPERAZINYL)-1,2-BENZISOTHIAZOLE

METABOLITE -> PARENT


					XE378JC4E6

3-(PIPERAZIN-1-YL)-1,2-BENZOTHIAZOLE-1,1-DIONE

METABOLITE -> PARENT

Interaction Type:

MAJOR


					J8Q2SF4XUL

6-CHLORO-5-(2-PIPERAZIN-1-YLETHYL)INDOLIN-2-ONE

METABOLITE -> PARENT


					CWM555KT4Q

S-METHYL-DIHYDROZIPRASIDONE SULPHOXIDE

METABOLITE -> PARENT


					S2229N6UPJ

BENZISOTHIAZOLE SULPHOXIDE

METABOLITE -> PARENT

Interaction Type:

MAJOR


					247Y55EP9X

2-(6-CHLORO-2-OXO-INDOLIN-5-YL)ACETIC ACID

METABOLITE -> PARENT


					KT78NQS9NT

S-METHYL-DIHYDROZIPRASIDONE

METABOLITE -> PARENT

Interaction Type:

MAJOR

Related Record Type Details


					6UKA5VEJ6X

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Volume of Distribution	PHARMACOKINETIC

Biological Half-life	PHARMACOKINETIC